Chapter 37. Atrial Fibrillation: Antiarrhythmic Therapy

  1. Salim Yusuf1,
  2. John A Cairns2,
  3. A John Camm3,
  4. Ernest L Fallen4 and
  5. Bernard J Gersh5
  1. Harry JGM Crijns,
  2. Isabelle C Van Gelder,
  3. Irina Savelieva and
  4. A John Camm

Published Online: 4 OCT 2007

DOI: 10.1002/9780470986882.ch37

Evidence-based Cardiology, Second Edition

Evidence-based Cardiology, Second Edition

How to Cite

Crijns, H. J., Van Gelder, I. C., Savelieva, I. and Camm, A. J. (2002) Atrial Fibrillation: Antiarrhythmic Therapy, in Evidence-based Cardiology, Second Edition (eds S. Yusuf, J. A. Cairns, A. J. Camm, E. L. Fallen and B. J. Gersh), BMJ Books, London, UK. doi: 10.1002/9780470986882.ch37

Editor Information

  1. 1

    Heart and Stroke Foundation of Ontario Research Chair, Senior Scientist of the Canadian Institute of Health Research, Director of Cardiology and Professor of Medicine, McMaster, University, Hamilton Health Sciences, Hamilton, Canada

  2. 2

    Dean, Faculty of Medicine, University of British Columbia, Vancouver, Canada

  3. 3

    Professor of Clinical Cardiology and Chief, Department of Cardiological Sciences, St George's Hospital Medical School, London, UK

  4. 4

    Professor Emeritus, McMaster University, Faculty of Health Sciences, Hamilton, Canada

  5. 5

    Consultant in Cardiovascular Diseases and Internal Medicine, Mayo Clinic; Professor of Medicine, Mayo Medical School, Rochester, Minnesota, USA

Publication History

  1. Published Online: 4 OCT 2007
  2. Published Print: 20 NOV 2002

ISBN Information

Print ISBN: 9780727916990

Online ISBN: 9780470986882



  • atrial fibrillation;
  • adrenergic tone;
  • hemodynamic consequences;
  • mortality;
  • atrial size enhancement


This chapter contains sections titled:

  • Definition of the arrhythmia

  • Natural history and pathophysiology

  • Clinical impact

  • Antiarrhythmic therapy of atrial fibrillation

  • Conclusion

  • Acknowledgments